CVS Health price target raised to $70 from $66 at Deutsche Bank
Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...
Analysts Are Bullish on Top Healthcare Stocks: CVS Health (CVS), Ultragenyx Pharmaceutical (RARE)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVS Health (CVS – Research Report) and ...
After more than 1,000 layoffs, worries persist about CVS Health's future in Connecticut
CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the ...
Why CVS Stock Thrashed the Market on Thursday
The positive investor sentiment on CVS is due to the pharmacy chain operator's fourth-quarter earnings report, which were published early Wednesday morning. The company squeaked past the consensus ...
CVS needs a more streamlined healthcare services strategy: CEO Joyner
CEO David Joyner has an ambitious plan to revamp the company's retail healthcare business and create a more integrated system ...
CVS wins upgrade to buy as analyst sees more upside potential than its peers
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...